[144] PEGASYSTEMS INC SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Pegasystems, Inc. (PEGA) shows a proposed sale of 2,544 common shares by an insider through Morgan Stanley Smith Barney, with an aggregate market value of $150,096.00 and an approximate sale date of 09/15/2025 on NASDAQ. The securities were acquired on 09/15/2025 by exercising options under a registered plan and payment was in cash. The filing lists four prior small sales by the same person between 07/28/2025 and 09/11/2025 totaling 1,401 shares. The filer represents there is no undisclosed material adverse information.

Insights

Financial Analyst

TL;DR: Routine insider exercise and planned sale; limited market impact given small size relative to outstanding shares.

The filing documents an insider exercise of options and a proposed sale of 2,544 shares valued at $150,096, executed through a broker on NASDAQ. With 171,080,665 shares outstanding reported in the form, the transaction represents a de minimis percentage of float. Recent small dispositions totaling 1,401 shares over the past months indicate routine liquidity activity rather than a material change in insider sentiment. No earnings or operational data are disclosed in this filing.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; contains standard representations and broker information.

The notice includes required details: broker name and address, acquisition method (exercise under registered plan), dates, and past transactions by the same person. The signer certifies absence of undisclosed material adverse information. There is no indication of a trading plan date or 10b5-1 election disclosed in the remarks. Documentation appears procedural and compliant with Rule 144 notice obligations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2544	150096.00	171080665	09/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Exercise of options under a registered plan	Issuer			2544	09/15/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
EFSTATHIOS A KOUNINIS 225 Wyman Street Waltham MA 02451	Common	09/11/2025	252	14490.00
EFSTATHIOS A KOUNINIS 225 Wyman Street Waltham MA 02451	Common	09/08/2025	332	19132.06
EFSTATHIOS A KOUNINIS 225 Wyman Street Waltham MA 02451	Common	09/05/2025	235	12925.00
EFSTATHIOS A KOUNINIS 225 Wyman Street Waltham MA 02451	Common	07/28/2025	582	34966.30

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for PEGA disclose?

The Form 144 discloses a proposed sale of 2,544 common shares valued at $150,096.00, acquired by exercise on 09/15/2025, to be sold on NASDAQ.

Who is the broker handling the PEGA stock sale listed on the Form 144?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

How many PEGA shares are outstanding according to the Form 144?

The filing reports 171,080,665 shares outstanding.

Has the filer sold PEGA shares recently before this proposed sale?

Yes. The filing lists four sales on 07/28/2025, 09/05/2025, 09/08/2025, and 09/11/2025 totaling 1,401 shares and gross proceeds shown for each sale.

How were the shares to be sold acquired according to the filing?

The 2,544 shares were acquired on 09/15/2025 by exercise of options under a registered plan and payment was made in cash.